logo

Centre de Preuves en Dermatologie Best practice guidelines

Guidelines classic scabies: in children < 15kg, pregnant or breastfeeding women Updated on Jan 24

Responsibility


The information provided by this website comes from sources deemed reliable. However, the Société Française de Dermatologie recommends that the user ensure the validity of this information. Some may prove to be erroneous or be subject to typos or display errors.

The use of this data is under the sole responsibility of the user. The Société Française de Dermatologie cannot be blamed for a misinterpretation of the data provided by the site, or in the event of erroneous information. This decision tree and all the contents of this site have been developed in the context of updated data from science according to the HAS methodology, expert opinions and reviewers of the various documents and in the context of the French healthcare system.


Pregnant woman with classic Scabies

Back to decision-making tree Print last updated on 29/08/2024

Treatment in case of failure

Repeat the initial treatment


After confirming failure and analyzing the conditions leading to failure (recontamination or poor compliance, intolerance to local treatment, poor decontamination of linen and bedding, treatment not renewed, contact subjects not treated simultaneously, etc.) :

Therapeutic proposal

or Use the same product or another among the 3 proposed products as a first-line treatment.
Prioritize oral Ivermectin 2 doses: D1 and between D8 and D14
if there is doubt about adherence, poor skin condition, or clustered cases. It is only recommended as second-line treatment in the 1st trimester of pregnancy due to lack of data and possible immaturity of the placental barrier.

Should a pregnant woman in contact with a case of scabies (primary circle) be treated?

  • Was this article helpful to you?
  • Your opinion counts!

    This notice will not be published on this site, but only sent to the publication management. Your email will only be used to reply to you if we deem it necessary. No response will be sent to any request for medical advice via this form.


Associated measures Topicals guidelines initial treatment

Centre de Preuves en Dermatologie Centre de Preuves en Dermatologie logo
Work
10 cité Malesherbes
75009Paris
Île-de-France
FRANCE
Work +33.1 43 27 01 56
Fax +33.1 43 27 01 86
centredepreuvesdermato@sfdermato.org